Using the newly developed approach for producing lipid nanoparticles (LNP) with and without DNA from a microfluidic setup, we propose to determine the detailed structures within the LNPs formed by an
LNP systems have played a critical role in the positive outcome of the COVID-19 vaccines. However, finding the optimised LNP formulations remains a significant challenge. It has been recognised that t
Figure S1. Transfection efficiency calculation: a. count total cells number (n) by Operetta; b. selected and counted GFP positive cells number (a). Transfection efficiency = (a/n) *100%. Figure S2. GF
